Relay Therapeutics, Inc. Shares Outstanding (Cover Page)
Relay Therapeutics, Inc. (RLAY) had Shares Outstanding (Cover Page) of 219.14 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 219.14M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 191.59M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 178.73M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 173.32M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 219.14M shares 10-Q · filed 2026-08-06 |
| 2026-05-01 | 191.59M shares 10-Q · filed 2026-05-05 |
| 2026-02-20 | 178.73M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 173.32M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 172.41M shares 10-Q · filed 2025-08-07 |
| 2025-05-02 | 171.44M shares 10-Q · filed 2025-05-05 |
| 2025-02-21 | 169.52M shares 10-K · filed 2025-02-26 |
| 2024-11-01 | 167.38M shares 10-Q · filed 2024-11-06 |
| 2024-08-02 | 133.89M shares 10-Q · filed 2024-08-06 |
| 2024-04-26 | 132.74M shares 10-Q · filed 2024-05-02 |
| 2024-02-16 | 131.18M shares 10-K · filed 2024-02-22 |
| 2023-10-27 | 123.27M shares 10-Q · filed 2023-11-02 |
| 2023-08-04 | 122.13M shares 10-Q · filed 2023-08-08 |
| 2023-04-28 | 121.61M shares 10-Q · filed 2023-05-04 |
| 2023-02-17 | 121.38M shares 10-K · filed 2023-02-23 |
| 2022-10-28 | 120.89M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 108.90M shares 10-Q · filed 2022-08-04 |
| 2022-04-29 | 108.66M shares 10-Q · filed 2022-05-05 |
| 2022-02-18 | 108.28M shares 10-K · filed 2022-02-24 |
| 2021-11-08 | 108.04M shares 10-Q · filed 2021-11-10 |
| 2021-08-10 | 92.70M shares 10-Q · filed 2021-08-12 |
| 2021-05-11 | 92.38M shares 10-Q · filed 2021-05-13 |
| 2021-03-23 | 90.40M shares 10-K · filed 2021-03-25 |
| 2020-11-10 | 89.98M shares 10-Q · filed 2020-11-12 |
| 2020-08-27 | 89.97M shares 10-Q · filed 2020-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |